Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Corrigendum to "Technical feasibility and life cycle assessment of an industrial waste as stabilizing product for unpaved roads, and influence of packaging" Sci. Total Environ. 651, Part 1, 15 February 2019, 1272-1282.

Balaguera A, Carvajal GI, Arias YP, Albertí J, Fullana-I-Palmer P.

Sci Total Environ. 2019 Jun 10;668:1341. doi: 10.1016/j.scitotenv.2019.02.304. Epub 2019 Mar 5. No abstract available.

PMID:
30846194
2.

Wearable EMG Shirt for Upper Limb Training.

Pino EJ, Arias Y, Aqueveque P.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:4406-4409. doi: 10.1109/EMBC.2018.8513107.

PMID:
30441329
3.

Technical feasibility and life cycle assessment of an industrial waste as stabilizing product for unpaved roads, and influence of packaging.

Balaguera A, Carvajal GI, Arias YP, Albertí J, Fullana-I-Palmer P.

Sci Total Environ. 2019 Feb 15;651(Pt 1):1272-1282. doi: 10.1016/j.scitotenv.2018.09.306. Epub 2018 Sep 24. Erratum in: Sci Total Environ. 2019 Jun 10;668:1341.

PMID:
30360259
4.

[Determination of HLA-A, -B and -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014].

Arias YR, Osorio-Arango K, Bayona B, Ercilla G, Beltrán-Durán M.

Biomedica. 2017 Jun 1;37(2):184-190. doi: 10.7705/biomedica.v37i2.3263. Spanish.

5.

[Implementation of the International Health Regulations in Cuba: evaluation of basic capacities of the health sector in selected provinces].

Gala Á, Toledo ME, Arias Y, Díaz González M, Alvarez Valdez AM, Estévez G, Abreu RM, Flores GK.

Rev Panam Salud Publica. 2012 Sep;32(3):207-16. Spanish.

PMID:
23183561
6.

In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.

Muñoz R, Arias Y, Ferreras JM, Jiménez P, Langa C, Rojo MA, Gayoso MJ, Córdoba-Díaz D, Bernabéu C, Girbés T.

Cancer Immunol Immunother. 2013 Mar;62(3):541-51. doi: 10.1007/s00262-012-1357-7. Epub 2012 Oct 18.

PMID:
23076642
7.

Transient injury-dependent up-regulation of CD105 and its specific targeting with an anti-vascular anti-mouse endoglin-nigrin b immunotoxin.

Muñoz R, Arias Y, Ferreras JM, Jiménez P, Rojo MÁ, Bernabéu C, Córdoba-Díaz D, Girbés T.

Med Chem. 2012 Nov;8(6):996-1002.

PMID:
22779758
8.

Plasma DNA restoration for PCR applications.

Arias YR, Carrillo EF, Aristizábal FA.

J Clin Pathol. 2007 Aug;60(8):952-4. No abstract available.

9.

Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b.

Muñoz R, Arias Y, Ferreras JM, Rojo MA, Gayoso MJ, Nocito M, Benitez J, Jiménez P, Bernabéu C, Girbés T.

Cancer Lett. 2007 Oct 18;256(1):73-80. Epub 2007 Jul 16.

PMID:
17637501
10.

Cytotoxicity of an ebulin l-anti-human CD105 immunotoxin on mouse fibroblasts (L929) and rat myoblasts (L6E9) cells expressing human CD105.

Benítez J, Ferreras JM, Muñoz R, Arias Y, Iglesias R, Córdoba-Díaz M, del Villar R, Girbés T.

Med Chem. 2005 Jan;1(1):65-70.

PMID:
16789887
11.

Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice.

Gayoso MJ, Muñoz R, Arias Y, Villar R, Rojo MA, Jiménez P, Ferreras JM, Aranguez I, Girbés T.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2):138-46.

PMID:
16102565
12.

Association between evening admissions and higher mortality rates in the pediatric intensive care unit.

Arias Y, Taylor DS, Marcin JP.

Pediatrics. 2004 Jun;113(6):e530-4.

PMID:
15173533
13.

Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses.

Girbes T, Ferreras JM, Arias FJ, Muñoz R, Iglesias R, Jimenez P, Rojo MA, Arias Y, Perez Y, Benitez J, Sanchez D, Gayoso MJ.

Cell Mol Biol (Noisy-le-grand). 2003 Jun;49(4):537-45. Review. Erratum in: Cell Mol Biol (Noisy-le-grand). 2004 Mar;50(2):205.

PMID:
12899446
14.

Cr(VI) reduction by sulfidogenic and nonsulfidogenic microbial consortia.

Arias YM, Tebo BM.

Appl Environ Microbiol. 2003 Mar;69(3):1847-53.

15.

Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b.

Muñoz R, Arias Y, Ferreras JM, Jiménez P, Rojo MA, Girbés T.

Cancer Lett. 2001 Jun 26;167(2):163-9.

PMID:
11369137
16.

Endoscopic sphincterotomy and laparoscopic cholecystectomy in a jaundiced infant.

Guelrud M, Rincones VZ, Jaen D, Toledano A, Arias Y.

Gastrointest Endosc. 1994 Jan-Feb;40(1):99-102. No abstract available.

PMID:
8163152

Supplemental Content

Support Center